Results 181 to 190 of about 31,914 (284)

Association of high-estimated glomerular filtration rate with the severity of ischemic stroke during non-vitamin K antagonist oral anticoagulants therapy: a nationwide cohort study. [PDF]

Front Neurol, 2023
Kang MK, Lee D, Oh MS, Lee JS, Jeong HY, Shin JH, Yoon BW, Park JM.   +7 more
europepmc   +1 more source

Cancer-Associated Thrombosis: A Taiwanese Perspective on Therapeutic Options with Focus on Non-Vitamin K Antagonist Oral Anticoagulants. [PDF]

Acta Cardiol Sin, 2023
Shao YY, Ho CL, Chang CS, Chang CL, Lee JK, Lin HJ, Hsiao HH, Chao TC, Lin CY, Liaw CC.   +9 more
europepmc   +1 more source

Cardiovascular outcomes in patients with atrial fibrillation concomitantly treated with antiarrhythmic drugs and non-vitamin k antagonist oral anticoagulants. [PDF]

Europace, 2023
Wu VC, Wang CL, Huang YC, Tu HT, Huang YT, Huang CH, Chen SW, Kuo CF, Hung KC, Chang SH.   +9 more
europepmc   +1 more source

Non-Vitamin K Antagonist Oral Anticoagulants versus Low Molecular Weight Heparin for Cancer-Related Venous Thromboembolic Events: Individual Patient Data Meta-Analysis. [PDF]

Cancers (Basel), 2023
Yau CE, Low CE, Ong NY, Rana S, Chew LJR, Tyebally SM, Chai P, Yeo TC, Chan MY, Lee MX, Tan LL, Koo CY, Lee ARYB, Sia CH.   +13 more
europepmc   +1 more source

Corrigendum to: 2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.

Europace, 2021
J. Steffel, R. Collins, M. Antz, P. Cornu, L. Desteghe, K. Haeusler, J. Oldgren, H. Reinecke, V. Roldán-Schilling, N. Rowell, P. Sinnaeve, T. Vanassche, T. Potpara, A. Camm, H. Heidbüchel   +14 more
semanticscholar   +1 more source

Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management—a joint position paper of the European Society of CardiologyWorking Group on Cardiovascular Pharmacotherapy and European Society of CardiologyWorking Group on Thrombosis [PDF]

, 2015
Agewall, Stefan, Atar, Dan, Drexel, Heinz, Elkjær Husted, Steen, Kaski, Juan, Kjeldsen, Keld, Koller, Lorenz, Lewis, Basil, Lip, Gregory, Morais, João, Niessner, Alexander, Storey, Robert, Tamargo, Juan, Torp-Pedersen, Christian, Verheugt, Freek, Wassmann, Sven   +15 more
core   +1 more source

Non-Vitamin K Antagonist Oral Anticoagulants for Thromboembolic Prevention in Patients with Atrial Fibrillation and Concomitant Mitral Stenosis: A Retrospective Observational Study. [PDF]

Acta Cardiol Sin
Liu HT, Lee HL, Wang YC, Chou SC, Chou CC.   +4 more
europepmc   +1 more source

Safety of off-label dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. [PDF]

Br J Clin Pharmacol, 2023
van den Dries CJ, Pajouheshnia R, van den Ham HA, Souverein P, Moons KGM, Hoes AW, Geersing GJ, van Doorn S.   +7 more
europepmc   +1 more source

Editorial Comment: Non-Vitamin K Antagonist Oral Anticoagulants for Thromboembolic Prevention in Patients with Atrial Fibrillation and Concomitant Mitral Stenosis: A Retrospective Observational Study. [PDF]

Acta Cardiol Sin
Liu CM, Chao TF.
europepmc   +1 more source

Clinical outcomes in patients with atrial fibrillation and a history of falls using non-vitamin K antagonist oral anticoagulants: A nationwide cohort study. [PDF]

Int J Cardiol Heart Vasc, 2023
Grymonprez M, Petrovic M, De Backer TL, Steurbaut S, Lahousse L.   +4 more
europepmc   +1 more source